|
Jul 31
|
SNDL Inc. (SNDL) Surpasses Q2 Earnings and Revenue Estimates
|
|
Jul 29
|
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 14
|
MacroGenics And 2 Other Promising Penny Stocks To Consider
|
|
Jul 11
|
MacroGenics, Inc. (NASDAQ:MGNX) is largely controlled by institutional shareholders who own 71% of the company
|
|
May 22
|
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
|
|
Apr 10
|
908 Devices Leads These 3 Penny Stocks To Consider
|
|
Feb 24
|
Discovering US Penny Stocks In February 2025
|
|
Feb 17
|
The past year for MacroGenics (NASDAQ:MGNX) investors has not been profitable
|
|
Sep 8
|
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
|
|
Jul 7
|
MacroGenics Insider Ups Holding By 83% During Year
|
|
Jun 11
|
MacroGenics to Participate in Upcoming Investor Conference
|
|
May 12
|
US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
|
|
May 10
|
Macrogenics Stock Drops 77% After Study Deaths
|
|
May 10
|
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
|
|
May 10
|
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript
|
|
May 10
|
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
|
|
May 3
|
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
|
|
Apr 19
|
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely
|
|
Apr 3
|
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
|